Genetic Predisposition clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Pancreatic Cancer Early Detection Consortium

    open to eligible people ages 18-90

    The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.

    at UCSD UCSF

Our lead scientists for Genetic Predisposition research studies include .

Last updated: